Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
7.9 NOK | -0.63% |
|
+5.33% | -36.29% |
2023 | Inify Laboratories Launches AI-Powered Cancer Diagnostic Services | MT |
2023 | Inify Laboratories Announces the Opening of Its First Laboratory | CI |
Business Summary
Sales per Business
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Diagnostics
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
NOK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Fredrik Palm
CEO | Chief Executive Officer | 49 | 21-11-09 |
Director of Finance/CFO | 52 | 21-12-31 | |
Arto Järvinen
CTO | Chief Tech/Sci/R&D Officer | 65 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 45 | 22-08-31 | |
Emelie Edvigsson
PRN | Corporate Officer/Principal | - | 21-12-31 |
Corporate Officer/Principal | 60 | - | |
Johanna Karling
LAW | General Counsel | 61 | 22-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lars Olof Sandèn
CHM | Chairman | 62 | 21-11-09 |
Magne Jordanger
BRD | Director/Board Member | 71 | 22-04-30 |
Director/Board Member | 69 | 21-11-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,236,750 | 6,345,658 ( 14.03 %) | 0 | 14.03 % |
Company contact information
![address INIFY Laboratories AB(INIFY)](https://cdn.zonebourse.com/static/address/139629936.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-36.29% | 34.04M | |
+7.23% | 217B | |
+11.31% | 191B | |
+28.94% | 154B | |
+32.00% | 112B | |
+0.11% | 62.75B | |
+16.09% | 53.34B | |
+0.94% | 48.88B | |
-2.97% | 39.36B | |
+1.23% | 35.73B |
- Stock Market
- Equities
- INIFY Stock
- Company INIFY Laboratories AB